Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

121

Citations

23

References

2017

Year

Gary T. Ferguson, J. Mark FitzGerald, Eugene R. Bleecker, Michel Laviolette, David I. Bernstein, Craig LaForce, Lyndon E. Mansfield, Peter Barker, Yanping Wu, Maria Jison,

The Lancet Respiratory Medicine

AsthmaRheumatologyAllergy MedicineClinical TrialsPulmonary PharmacologyPharmacotherapyPharmacologic InterventionPersistent AsthmaMedicineClinical Allergy

References

	Year	Citations

Page 1

Page 1